Literature DB >> 27030992

Notes from the Field: Baseline Assessment of the Use of Ebola Rapid Diagnostic Tests--Forécariah, Guinea, October-November 2015.

Jennifer Y Huang, Frantz Jean Louis, Meredith G Dixon, Marcel Sefu, Lon Kightlinger, Lise D Martel, Gayatri C Jayaraman, Abdou Salam Gueye.   

Abstract

The Ebola virus disease (Ebola) epidemic in West Africa began in Guinea in early 2014. The reemergence of Ebola and risk of ongoing, undetected transmission continues because of the potential for sexual transmission and other as yet unknown transmission pathways. On March 17, 2016, two new cases of Ebola in Guinea were confirmed by the World Health Organization. This reemergence of Ebola in Guinea is the first since the original outbreak in the country was declared over on December 29, 2015. The prefecture of Forécariah, in western Guinea, was considerably affected by Ebola in 2015, with an incidence rate of 159 cases per 100,000 persons. Guinea also has a high prevalence of malaria; in a nationwide 2012 survey, malaria prevalence was reported to be 44% among healthy children aged ≤5 years. Malaria is an important reason for seeking health care; during 2014, 34% of outpatient consultations were related to malaria.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27030992     DOI: 10.15585/mmwr.mm6512a4

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  7 in total

1.  Assessments of Ebola knowledge, attitudes and practices in Forécariah, Guinea and Kambia, Sierra Leone, July-August 2015.

Authors:  Mohamed F Jalloh; Rebecca Bunnell; Susan Robinson; Mohammad B Jalloh; Alpha Mamoudou Barry; Jamaica Corker; Paul Sengeh; Amanda VanSteelandt; Wenshu Li; Foday Dafae; Alpha Ahmadou Diallo; Lise D Martel; Sara Hersey; Barbara Marston; Oliver Morgan; John T Redd
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-26       Impact factor: 6.237

Review 2.  Diagnosis of Ebola Virus Disease: Past, Present, and Future.

Authors:  M Jana Broadhurst; Tim J G Brooks; Nira R Pollock
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

3.  Improving Ebola infection prevention and control in primary healthcare facilities in Sierra Leone: a single-group pretest post-test, mixed-methods study.

Authors:  Ruwan Ratnayake; Lara S Ho; Rashid Ansumana; Hannah Brown; Matthias Borchert; Laura Miller; Thomas Kratz; Shannon A McMahon; Foday Sahr
Journal:  BMJ Glob Health       Date:  2016-12-02

Review 4.  Key data for outbreak evaluation: building on the Ebola experience.

Authors:  Anne Cori; Christl A Donnelly; Ilaria Dorigatti; Neil M Ferguson; Christophe Fraser; Tini Garske; Thibaut Jombart; Gemma Nedjati-Gilani; Pierre Nouvellet; Steven Riley; Maria D Van Kerkhove; Harriet L Mills; Isobel M Blake
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-26       Impact factor: 6.237

5.  Operational evaluation of rapid diagnostic testing for Ebola Virus Disease in Guinean laboratories.

Authors:  Amanda VanSteelandt; Josephine Aho; Kristyn Franklin; Jacques Likofata; Jean Baptiste Kamgang; Sakoba Keita; Lamine Koivogui; N'Faly Magassouba; Lise D Martel; Anicet George Dahourou
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

6.  Ebola Response Impact on Public Health Programs, West Africa, 2014-2017.

Authors:  Barbara J Marston; E Kainne Dokubo; Amanda van Steelandt; Lise Martel; Desmond Williams; Sara Hersey; Amara Jambai; Sakoba Keita; Tolbert G Nyenswah; John T Redd
Journal:  Emerg Infect Dis       Date:  2017-12       Impact factor: 6.883

7.  Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.

Authors:  Peace Babirye; Carol Musubika; Samuel Kirimunda; Robert Downing; Julian J Lutwama; Edward K Mbidde; Jacqueline Weyer; Janusz T Paweska; Moses L Joloba; Misaki Wayengera
Journal:  BMC Infect Dis       Date:  2018-10-03       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.